s'authentifier
version française rss feed
!.. Document complet sous embargo ..!
Mise en ligne du document : document non public
Radiotherapy quality assurance by individualized in vivo dosimetry: state of the art.
Ismail A., Giraud J.-Y., Lu G.N., Sihanath R., Pittet P., Galvan J.-M., Balosso J.
Cancer/Radiothérapie 13, 3 (2009) 182-9 - http://www.hal.inserm.fr/inserm-00524577
(19272824)
Radiotherapy quality assurance by individualized in vivo dosimetry: state of the art.
A. Ismail1, 2, Jean-Yves Giraud2, G. N. Lu3, Roddy Sihanath2, Patrick Pittet3, Jean-Marc Galvan3, Jacques Balosso () 2
1 :  Radioprotection Department of Syrian Atomic Energy Commission
Syrian Atomic Energy Commission
Damascus
Syrienne, République Arabe
2 :  Département de cancérologie et radiothérapie
CHU Grenoble
France
3 :  INL - Institut des nanotechnologies de Lyon - Site d'Ecully
CNRS : UMR5270 – Université Claude Bernard - Lyon I – Institut National des Sciences Appliquées (INSA) - Lyon – Ecole Centrale de Lyon
bat. 7 36 Av Guy de Collongue - 163 69131 ECULLY CEDEX
France
The quality insurance in radiotherapy in the frame of highly complex technical process as Intensity modulated radiotherapy (IMRT) needs independent control of the delivered dose to the patient. Actually, up to now, most of the radiotherapy treatments rely only on computed dosimetry through a rather complicated series of linked simulation tool. This dosimetry approach requires also qualified treatment means based on cautious quality insurance procedures. However, erroneous parameters could be difficult to detect and systematical errors could happen leading to radiotherapy accidents. In this context, in vivo dosimetry has a critical role of final control of the delivered dose. As many beam incidences and ports are used for any photontherapy treatment, external control could be very tedious and time consuming. Therefore, innovations are needed for in vivo dosimetry to provide ergonomic and efficient tools for these controls. This paper presents a review of technologies and products that can be used for in vivo dosimetry. It proposes also a reflection on the concepts to develop future devices suitable for this purpose. The technical means with their physical principles are reviewed, the clinical experiences demonstrating the feasibility of new techniques are then summarized and finally, the early clinical use and its impact on clinical practice is review.
Sciences du Vivant/Cancérologie
Sciences du Vivant/Ingénierie biomédicale
Anglais
1278-3218

Articles dans des revues avec comité de lecture
10.1016/j.canrad.2009.01.001
Cancer/Radiothérapie
internationale
06/2009
09/03/2009
13
3
182-9

In vivo dosimetry – Electronic dosimeter – Semiconductors – Radiotherapy – Implantable radiation detectors
Humans – Neoplasms – Quality Assurance – Health Care – Radiation Monitoring – Radiometry – Radiotherapy Dosage
Référence du projet ANR-07-EMPB-028
Année 2007
Acronyme du projet EMPB
Titre du projet Développement d'un système de dosimétrie en temps réel implantable et extractible in vivo pour le contrôle des irradiations complexes en radiothérapie anti-cancéreuse.
Intitulé Emergence et maturation de projets en biotechnologies et technologies de la santé
Acronyme de l'appel SECURIDOSE

tous les articles de la base du CCSd...